INFORMATION FOR
News
The Yale Department of Internal Medicine is pleased to highlight the following professors: Carlos Mena, MD, Edward Miller, MD, PhD, Yibing Qyang, PhD, and Jeffrey Testani, MD, MTR.
A new study by Yale researchers reveals a new method of developing tissue-engineered vascular conduits that offer promising benefits to patients with single ventricle heart defects.
The National Institutes of Health (NIH) recently awarded Yibing Qyang, PhD, and his colleagues a $2+ million R01 grant to support research to create an artificial blood vessel that can grow, pump, and resist infection and clotting.
Óscar Bártulos-Encinas, PhD, reflects on his transition from the Yale Cardiovascular Research Center to industry.
Yale offers degree-granting programs, funding mechanisms, and advanced research training to pursue a career in academic medicine.
Research led by Muhammad Riaz, PhD, Jinkyu Park, PhD, and Lorenzo Sewanan, MD, PhD, provides a mechanism to identify abnormalities linked with hypertrophic cardiomyopathy.
Ehimen Aneni, MD, MPH, has been awarded a two-year KL-2 grant to assess the cardiovascular benefits of treating sleep apnea.
When patients need a vascular graft, as during heart bypass surgery, surgeons often use blood vessels from elsewhere in the body, but these are not always available. As an alternative, Yale researchers led by Yibing Qyang, PhD, associate professor of medicine (cardiology) and of pathology, are..
Yale doctors have developed a way to create vascular grafts from stem cells that are as strong as the original blood vessels they would replace.
Yibing Qyang, PhD, has received $2 million in peer-reviewed medical research funding. The project proposes to use hiPSC-derived heart muscle cells to improve the pumping activity of tissue-engineered pulsatile conduits.
NEW HAVEN, Conn. (WTNH) – The fight against heart disease is the focus of Yale scientists working with stem cells. Bio-engineered smooth tissue, made of stem cells, induced from blood cells directly taken from patients with cardiovascular disease.
There is strength in numbers, and in unity, as members of the Yale Cardiovascular Research Center (YCVRC) know. Less than a year after moving into new laboratory space expressly designed to foster collaboration and shared resources, the 16-person team, led by YCVRC Director Michael Simons, M.